Publication | Closed Access

Novel aryl carboximidamide and 3-aryl-1,2,4-oxadiazole analogues of naproxen as dual selective COX-2/15-LOX inhibitors: Design, synthesis and docking studies

Combinatorial ChemistryMedicinal ChemistryPharmaceutical ChemistryDocking StudiesMedicinePharmacological AgentNovel Aryl CarboximidamidePharmacotherapyAnti-cancer AgentDrug DevelopmentPharmacologyRadiation Oncology3-Aryl-1,2,4-oxadiazole AnaloguesDrug Discovery